Molnupiravir N-1 CAS 2346620-55-9 COVID-19 Babban inganci

Takaitaccen Bayani:

Sunan samfur: Molnupiravir N-1

Saukewa: 2346620-55

Bayyanar: Fari zuwa Kashe-fari foda

Tsafta: ≥98.0%

Matsakaicin Molnupiravir (CAS 2349386-89-4) a cikin maganin COVID-19

Kyakkyawan inganci, Samar da Kasuwanci

Inquiry: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Samar da Kasuwancin Molnupiravir da Matsakaici masu alaƙa tare da Ingantacciyar inganci
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4

Abubuwan Sinadarai:

Sunan Sinadari Molnupiravir N-1
Makamantu ((3aR,4R,6R,6aR) -6-((E) -4- (hydroxyimino) -2-oxo-3,4-dihydropyrimidin-1 (2H) -yl) -2,2-dimethyltetrahydrofuro[3, 4-d [1,3] dioxol-4-yl) methyl isobutyrate;Molnupiravir Intermediate;Molnupiravir Dimethyl Dioxol rashin tsabta;Molnupiravir 11
Lambar CAS 2346620-55-9
Lambar CAT Saukewa: RF-PI310
Matsayin Hannun jari A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram
Tsarin kwayoyin halitta Saukewa: C16H23N3O7
Nauyin Kwayoyin Halitta 369.37
Solubility Mai narkewa a cikin DMSO
Yawan yawa 1.51± 0.1 g/cm3
Zazzabi na jigilar kaya Na yanayi
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Fari zuwa Kashe-Farin Foda
Asara akan bushewa ≤1.0%
Ragowa akan Ignition ≤0.20%
Tsaftace Guda Daya ≤0.50%
Jimlar ƙazanta ≤2.0%
Karfe masu nauyi ≤20ppm
Tsafta ≥98.0%
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Molnupiravir (CAS 2349386-89-4) COVID-19

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.

Amfani:

1

FAQ:

Aikace-aikace:

Molnupiravir N-1 (CAS 2346620-55-9), shine matsakaicin Molnupiravir (CAS 2349386-89-4) a cikin maganin COVID-19.Molnupiravir (EIDD-2801) wani nau'in halitta ne na baka mai ƙarfi na analog mai ƙarfi na ribonucleoside wanda ke hana kwafin ƙwayoyin cuta na RNA da yawa ciki har da SARS-CoV-2, wakilin cutar COVID-19.EIDD-2801 (7 mg/kg; po; sau biyu a rana don kwanaki 3.5) yana rage yawan zubar da kwayar cutar da tsawon lokacin zazzabi.Molnupiravir (EIDD-2801) yana da ingantaccen hydrolyzed a cikin vivo bayan sha, yana haifar da gano NHC kyauta kawai a cikin plasma.EIDD-2801 da ƙarfi yana rage masu kamuwa da cutar MERS-CoV, kwayar cutar RNA, da pathogenesis ƙarƙashin duka prophylactic da farkon yanayin warkewa.Molnupiravir (EIDD-2801, MK-4482) wani prodrug ne na baki bioavailable prodrug na ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931) tare da m-bakan antiviral aiki a kan SARS-CoV-2, MERS-CoV, SARS-CoV, kuma wakili mai haifar da COVID-19.

Ku rubuta sakonku anan ku aiko mana